| Cancer: |
| FDA investigates possible Vytorin link to cancer (AP) |
| AP - Federal drug safety regulators said Thursday they are investigating whether the cholesterol-lowering drug Vytorin can increase patients' risk of developing cancer. |
| Osteo Drug Stops Bone Loss From Breast Cancer Chemo (HealthDay) |
| HealthDay - THURSDAY, Aug. 21 (HealthDay News) -- The osteoporosis drug Zometa
(zoledronic acid) prevented bone loss at 12 months in premenopausal women
undergoing chemotherapy after they had surgery for early stage breast
cancer, a new study found. |
| Scientists identify chemical odor of skin cancer: study (AFP) |
| AFP - US chemists have identified the odor that emanates from skin cancer, a development that researchers hope will advance diagnosis and treatment of the deadly disease, said a study out Wednesday. |
| Health Highlights: Aug. 20, 2008 (HealthDay) |
| HealthDay - Here are some of the latest health and medical news developments,
compiled by editors of HealthDay: |
| Cholesterol-Lowering Drugs Won't Cause Cancer (HealthDay) |
| HealthDay - WEDNESDAY, Aug. 20 (HealthDay News) -- Researchers who last year
reported a possible link between cholesterol-lowering statin drugs and
cancer now say that further analysis has disproved such an association. |
| Skin Cancer Carries Its Own Scent (HealthDay) |
| HealthDay - WEDNESDAY, Aug. 20 (HealthDay News) -- Researchers have
identified an "odor profile" for skin cancer, with an eye toward
developing a fast, simple and noninvasive test to diagnose the most common
form of skin cancer in the United States. |
| Cervical Cancer Vaccine Worth the Cost: Study (HealthDay) |
| HealthDay - WEDNESDAY, Aug. 20 (HealthDay News) -- Vaccinating all
12-year-old girls against the virus that causes cervical cancer, along
with "catch-up" immunizations of women under the age of 21 and revised
screening guidelines, would be cost-effective ways to combat the disease,
a new study by Harvard researchers suggests. |
| Cervical cancer shots less cost-effective with age (AP) |
| AP - An expensive vaccine aimed at preventing cervical cancer makes sense for young teens when it comes to cost-effectiveness, but not for women in their 20s, contends a new report. |
|
